Enzyan Biocatalysis GmbH
Stefan Payer is a highly experienced professional in the field of chemistry and biocatalysis, currently serving as the CEO and Co-Founder of Enzyan Biocatalysis GmbH since March 2022. Prior to this role, Stefan Payer was a Postdoctoral Researcher at Karl-Franzens-Universität Graz, where the focus was on the development of 2-oxoglutarate-dependent biocatalysts for the synthesis of active pharmaceutical ingredients (APIs) and natural products from October 2021 to August 2022. Earlier experience includes a Postdoctoral Research Fellow position at the University of California, Berkeley, specializing in bio-inspired total synthesis of alkaloid natural products from January 2020 to July 2021. Stefan Payer holds a Doctor of Philosophy (PhD) in Organic Chemistry from the University of Graz, as well as Master of Science (MS) degrees in Chemistry from Technische Universität Graz and the University of Utah through an International Student Exchange Program.
This person is not in the org chart
This person is not in any teams
Enzyan Biocatalysis GmbH
Enzyan Biocatalysis aims to provide industrial partners the tools for the implementation of green and more economic biomanufacturing processes for (fine) chemicals/pharmaceuticals. This is achieved by the identification, development, and optimization of potentially more efficient and sustainable synthetic routes. We use a broad set of tools to test the production of biocatalysts in Escherichia coli and characterize enzymes in view of their biocatalytic properties. We design biocatalytic routes and enzymatic cascades and identify the optimal process parameters by combining a highly automated and integrated wet-lab infrastructure, professional personnel, and cutting-edge computational tools. The expertise in solving challenging problems at the interface of synthetic chemistry and enzymatic transformations is considered the core strength of the company.